NCT06671184 Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
| NCT ID | NCT06671184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai 6th People's Hospital |
| Condition | Differentiated Thyroid Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
No prior studies have stratified the difficulty of transoral and submental thyroidectomy (TOaST). The investigators aimed to investigate preoperative factors as indicators of difficult TOaSTs and to develop a predictive model accordingly.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm * Absence of suspicious lateral lymph nodes or distant metastases * Participants with high cosmetic expectations * Participants who underwent total thyroidectomy and central lymph node dissection. Exclusion Criteria: * Participants with fusion or fixation of lymph nodes in the neck * Participants with history of neck surgery or radiation * Participants with vocal fold fixation by preoperative fibrolaryngoscope * Participants with preoperative examination suggestive of extrathyroidal invasion * Participants with a significantly restricted neck
Contact & Investigator
Ling Zhan, Doctor
PRINCIPAL INVESTIGATOR
Shanghai 6th People's Hospital
Frequently Asked Questions
Who can join the NCT06671184 clinical trial?
This trial is open to participants of all sexes, studying Differentiated Thyroid Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06671184 currently recruiting?
Yes, NCT06671184 is actively recruiting participants. Contact the research team at rebecca0428zhan@163.com for enrollment information.
Where is the NCT06671184 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06671184 clinical trial?
NCT06671184 is sponsored by Shanghai 6th People's Hospital. The principal investigator is Ling Zhan, Doctor at Shanghai 6th People's Hospital. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.